Biochemistry, Genetics and Molecular Biology
Monospecific Antibody
100%
T Cell
50%
Mouse
44%
Glycosylation
33%
Surface Property
33%
Lysine
33%
Oligonucleotide
33%
Recombinant Protein
33%
Copurification
33%
Dynein
33%
Cell Growth
33%
Drive
33%
Complementarity Determining Region
33%
Agonist
33%
Tumor Immunity
33%
Caenorhabditis Elegans
33%
Escherichia coli
33%
Epidermal Growth Factor Receptor
33%
C-Terminus
33%
Monoclonal Antibody
33%
DNA Template
33%
N-Terminus
25%
Tumor Progression
22%
Cancer Immunotherapy
19%
Pharmacokinetics
16%
Phagemid
16%
Antineoplastic Activity
16%
Protein Tag
16%
Protein Expression
16%
Plasmid
16%
Rigidity
16%
Deoxyribonuclease
16%
Neonatal Fc Receptor
14%
Luciferase
11%
Wild Type
11%
Light Chain
11%
Amino Acids
11%
Cancer Cell
11%
Nuclear Membrane
11%
CRISPR/Cas9
11%
Peripheral Blood Mononuclear Cell
9%
Urate Oxidase
8%
Medical Biology
8%
Serum Total Protein
8%
Synuclein
8%
Immunoglobulin G
8%
Cell Culture
8%
Enzyme
8%
Heavy Chain
7%
Cell Infiltration
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
75%
Malignant Neoplasm
47%
Epidermal Growth Factor Receptor
44%
Immunotherapy
38%
SARS Coronavirus
33%
Drug Development
33%
Albumin Antibody
33%
Prostate Cancer
33%
Angiotensin Converting Enzyme 2
33%
Human Albumin
27%
Immunoglobulin
20%
Monoclonal Antibody
19%
Mouse
19%
Tumor Growth
16%
Pharmacokinetics
13%
Fc Receptor
12%
Biological Product
12%
Cytotoxicity
12%
Disease
11%
Coronavirinae
11%
Transgenic Mouse
11%
Albumin
8%
Combination Therapy
8%
Mouse Model
8%
Luciferase
8%
Colorectal Cancer
8%
Antivirus Agent
8%
Amino Acid
8%
CD8 Antigen
8%
Nanobody
8%
Breast Cancer
8%
Cancer Inhibition
5%
Bispecific Antibody
5%
Tumor Microenvironment
5%
Infection
5%
Therapeutic Effect
5%
Vitronectin
5%
Medicine and Dentistry
T Cell
33%
Neoplasm
33%
Prostate Cancer
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Immunotherapy
33%
Life Extension
33%
Albumin Antibody
33%
Tumor Immunity
33%
Angiotensin Converting Enzyme 2
33%
Human Albumin
25%
Monoclonal Antibody
22%
Epidermal Growth Factor Receptor
22%
In Vitro
16%
Cancer Immunotherapy
15%
Cancer Inhibition
11%
Therapy Effect
11%
Pharmacokinetics
11%
COVID-19
11%
Tumor Microenvironment
11%
Bispecific Antibody
11%
Specific Tumor
11%
Antineoplastic Activity
11%
T Lymphocyte
11%
Cytotoxic T-Cell
8%
Cellular Infiltration
8%
Plasma Half Life
8%
Interferometry
6%
Vitronectin
5%
Antiviral Therapeutics
5%
Infection
5%
